SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-15-032029
Filing Date
2015-05-18
Accepted
2015-05-18 16:47:23
Documents
1
Period of Report
2015-05-15

Document Format Files

Seq Description Document Type Size
1 form474501_20150518044731-.html 4  
1 form474501_20150518044731-.xml 4 3893
  Complete submission text file 0001144204-15-032029.txt   5344
Mailing Address AUXILIUM PHARMACEUTICALS, INC. 40 VALLEY STREAM PARKWAY MALVERN PA 19355
Business Address
Mattila Jyrki (Reporting) CIK: 0001297318 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36357 | Film No.: 15873799

Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Issuer) CIK: 0001535955 (see all company filings)

IRS No.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations